テキサスにおける双極性障害の臨床試験
テキサス内の拠点で、双極性障害に関する16件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- 他3件
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- The University of Texas at Austin, Austin
- REX Clinical Trials LLC, Beaumont
- Kaleidoscope Clinical Research, Houston
- 他1件
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06372964A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Revival Research Institute, LLC, McKinney
- Pillar Clinical Research - Richardson, Richardson
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07286175A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Elevate Synapsis, LLC, Atascocita
- Memorial Hermann Village, Houston
- Grayline Research Center, Wichita Falls
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/02更新 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Community Clinical Research - Cross Park Drive /ID# 272940, Austin
- Elixia - Houston /ID# 279200, Houston
- Mind Matters Psychiatry /ID# 273536, Missouri City
- 他2件
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/14更新 · NCT06696755Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第2相
25歳〜70歳 · 全性別 · 2026/08/12更新 · NCT06706232Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
被験者募集中第1相
10歳〜17歳 · 全性別 · 2026/08/11更新 · NCT05025605A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Community Clinical Research, Austin
- Elevate Clinical Research-Houston, Houston
- Prime Clinical Research - Mansfield, Mansfield
- 他1件
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/06/23更新 · NCT07140913FOCUS Bipolar: Families Opening Conversations for Understanding Signs
- UT Southwestern Medical Center, Dallas
被験者募集中観察研究健康なボランティア歓迎
7歳以上 · 全性別 · 2026/06/03更新 · NCT07622927Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳〜50歳 · 全性別 · 2026/02/18更新 · NCT05240352Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
- Baylor College of Medicine, Houston
被験者募集中
22歳〜64歳 · 全性別 · 2026/01/26更新 · NCT06599099Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
- University of Texas at Austin, Austin
被験者募集中健康なボランティア歓迎
21歳〜26歳 · 全性別 · 2026/01/12更新 · NCT05838274Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
22歳〜85歳 · 全性別 · 2025/12/03更新 · NCT04080778Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第1相
18歳〜65歳 · 全性別 · 2025/06/22更新 · NCT03522545ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。